Stock Update (NYSE:STJ): St. Jude Medical Announces Fourth Quarter and Full-Year 2015 Earnings Conference Call

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced that it will report financial results for its fourth quarter and full-year 2015 results on Wednesday, January 27, 2016. Read more on this. St. Jude Medical Inc. (STJ) , valued at $16.99B, started the session at $59.85. During today’s session, STJ traded between $59.71 to $60.60 with a trailing 52-week range being $59.71 to $80.84. STJ shares are currently priced at 15.47x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 11.64x earnings multiple for the same period. And for passive income investors, the company pays shareholders $1.16 per share annually in dividends, yielding 1.88%. In a review of the consensus earnings estimate this quarter, 24 sell-side analysts are looking at $1.02 per share, which would be $0.01 worse than the year-ago quarter and a $0.04 sequential decrease. Investors should also note that the full-year EPS estimate of $3.93 is a $0.05 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $1.48 Billion. If realized, that would be a 2.78% increase over the year-ago quarter. Recently, Stifel downgraded STJ from Buy to Hold (Oct 22, 2015). Previously, Deutsche Bank downgraded STJ from Buy to Hold. With the above information in mind, readers should note that the average price target is $73.50, which is 22.81% above where the stock opened this morning. See more in (NYSE:STJ) Similar Articles: Market Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces Leadership Transition Plan Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Reports Second Quarter 2015 Results Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces FDA Approval for Industry’s Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.